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ABSTRACT

A method of enhancing the tenderness of meat for animal or
human consumption by treatment of pre-rigor muscle with
the compositions of the invention. It has been found that
other quality meat traits can also be enhanced with the
method of the invention.
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METHODS AND COMPOSITIONS TO ENHANCE
TENDERNESS AND VALUE OF MEAT

0001. This application is related to U. S. Provisional
Application, Ser. No. 60/204,210, filed May 12, 2000, which
is incorporated herein by reference.
BACKGROUND OF INVENTION

0002 The present invention relates generally to enhance
ment of desirable attributes of meat; compositions and
methods for accomplishing Such enhancement; and to the
meat enhanced by Such compositions and methods. More
particularly, the present invention relates to the treatment of
whole pre-rigor Skeletal muscle, either while on the carcass
or after excision, employing compositions of the invention
which are applied to pre-rigor muscle to obtain a significant
enhancement in tenderneSS and other desirable attributes of
meat.

0003. The publications and other materials used herein to
illuminate the background of the invention, and in particular
cases, to provide additional details respecting the practice,
are incorporated by reference, and for convenience are
referenced in the following text by author and date and are
listed alphabetically by author in the attachments hereto.
0004 Tenderness is reported to be the trait most affecting
consumer acceptance of beef, while lean color is reportedly

the most important attribute at point of purchase (Faustman
and Cassens, 1991). Tenderness of meat is the sum total of
the mechanical Strength of skeletal muscle tissue and its

weakening during postmortem aging of meat (Takahashi,
1996). Kamstra and Saffle (1959) described tenderness as an
elusive characteristic because many of the factors which
contribute to it are in a continual State of change from the
time of animal Slaughter. Much research during the past 50
years has been devoted to study of the numerous factors that
have been implicated in tenderneSS, Such as age, breed, Sex,
fatness, pre-Slaughter treatments, dressing, cooling, Storage
and cooking procedures. The relationship between normal
early-postmortem changes and tenderneSS have been inves
tigated. The rate at which these changes occur influences
important meat quality traits Such as tenderness, color and

water-holding capacity (Hamm, 1982).
0005. The U.S. beef and pork industries have funded
research to improve the quality, consistency and uniformity
of beef. Much of this research has been directed to improve
ment through treatment of meat after it has gone through

rigor mortis (post-rigor). There is an important difference
between pre-rigor treatment and post-rigor treatment of
meat. Several post-rigor treatments have been promoted as
a way to enhance tenderneSS. The best known of these has
been calcium chloride. This compound is reported to
enhance the activity of proteolytic enzymes within meat that
naturally improve meat tenderneSS upon extended cold Stor

age (aging).
0006 Previous work with sodium chloride was under
taken to reduce the Sodium content of Sausage-type (ground/
processed) meat products. (Bernthal et al., 1989) The effects
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of Sodium chloride on processing characteristics of the meat
in Sausage formulations has also been evaluated. However,
the possible effect of sodium chloride on tenderness of
whole and unground muscle has not been reported. Simi
larly, the use of glucose has been evaluated as a way to
reduce the amount of Sodium added to Sausage ingredients.

(Young et al., 1988) Dalrymple and Hamm (1974) showed
that Salt addition to pre-rigor muscle minces reduced phos
phorylase activity. Phosphates have been used at levels of
1-2% to increase the amount of water bound by muscle, i.e.,
to improve water holding capacity, by increasing meat pH

and solubilizing proteins (Bernthal et al., 1991). Alvarez
(1996) and Martin-Herrera (1998) reported the use of
sodium fluoride and calcium fluoride (200 mM) to inhibit

enolase and improve tenderneSS by increasing pH in pre
rigor beef muscles.
0007 Of the above attempts to alter attributes of pre-rigor
muscle, each has disadvantages. For example, both Salt and
phosphate impart distinct flavor profiles and frequently alter
color. Salt is also a pro-oxidant and its use increases oxida
tive rancidity and reduces color stability of meat. Use of
phosphate is limited by law to 0.5% and, furthermore, it
generates Soapy flavors at high levels. Sodium acetate and

Sodium citrate have been added to meat to enhance shelf life.

Citric acid sprays have been used as a Surface Spray for
animal carcasses to inhibit microbial growth. Acid marina
tion causes Significant flavor changes and can alter the
texture of the meat and make it mushy. Sodium fluoride has
been reported to enhance tenderneSS and maintain fresh meat
color, however, sodium fluoride is not approved in the U.S.
for addition to meat products.
0008 Most beef is cut into steaks and roasts, or ground
for ground beef, after it has undergone a chilling process
following harvest. This allows the normal rigor mortis

(rigor) process to occur within muscle. One consequence of
rigor development is production of lactic acid within the
meat, resulting in a pH lower than pre-rigor muscle.
Although the pH of different post-mortem muscle types can
be quite different, meat of a given type which has a relatively
higher pH is generally associated with an increased tender

ization (Harrell et al., 1978; Watanabe et al., 1996; Beltranet
al., 1997). The increased tenderness at high pH has been
attributed by some to the direct effect of pH on the activity
of the proteolytic enzymes which degrade the myofibrillar

structure of the muscle (Yu and Lee, 1986). However, the
results of investigations of the effect of pH on tenderneSS

have been inconsistent. For example, Wulf et al. (1997),
reports that higher pH (dark-cutting) beef is less tender.
0009. Although there are reports of the beneficial effect
of pH on tenderneSS of meat, high pH meat is quite dark in
color and SufferS Severe loSS in value as a consequence.
However, as with studies of the correlation of pH and
tenderness, the reported association of color with tenderneSS

is inconsistent. Wulf et al. (1997) reported that dark-cutting
beef is less tender. Conversely, Jeremiah et al. (1991)
reported that beef carcass with dark color produced more
tender Steaks. Strategies to increase pH while preserving
desirable color would be of importance to the industry.
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0.010 Changes in another attribute of muscle, sarcomere
length (SL), have been reported to be related to tenderness.
Longer Sarcomeres have been associated with greater ten

derness (Hostetler et al., 1972; Bouton et al., 1973; Davis et
al., 1979; Koohmaraie et al., 1996). Muscles shorten when

they enter the rigor State. Temperature and pH also have
been reported to play an important role in Sarcomere length.

Hertzman et al. (1993) showed that the rate of shortening
increases with increasing temperature from 10° C. to 37 C.
However, temperatures below 10° C. in more severe short
ening (Honikel et al., 1981). Locker and Hagyard (1963)
reported minimum shortening between 15 and 20° C. for
Sternomandibularis beef muscles.

0.011 Among muscle types, there are significant differ
ences in the pattern of postmortem glycolysis and the onset

of rigor (Ouali and Talmant, 1990). Meat quality attributes,
including color, texture and tenderness, are also related to

fiber characteristics of the muscle (Cassens and Cooper,
1971).
0012. A method which enhances tenderness while main
taining desirable color of a wide Spectrum of muscle types
would upgrade the value, especially of lower-value cuts, and
enhance customer Satisfaction. It is desired to develop a
treatment for beef which enhances tenderness of diverse

muscle types, without over-tenderization. It is also desired to
find a treatment to enhance tenderneSS which will not

negatively impact meat color or flavor.
SUMMARY OF INVENTION

0013 The present invention relates generally to enhance
ment of desirable attributes of meat; compositions and
methods for accomplishing Such enhancement; and to the
meat enhanced by Such compositions and methods. More
particularly, the present invention relates to the treatment of
pre-rigor muscle, either while on the carcass or after exci
Sion, employing compositions of the invention which are
applied to pre-rigor muscle to obtain a significant enhance
ment in tenderneSS and other desirable attributes of meat.
BRIEF DESCRIPTION OF THE FIGURES IN
ATTACHMENTS

0.014 FIG. 1 shows the effects of marination on pH and
Shear force in pre-rigor longissimus lumborum muscle.
0015 FIG. 2 shows the effects of marination on pH and
Shear force in pre-rigor rectus abdominis muscle.
0016 FIG. 3 shows the effects of marination on pH and
Shear force in pre-rigor cutaneous trunci muscle.
0017 FIG. 4 shows effects of marination on visual color
in pre-rigor longissimus lumborum muscle.
0018 FIG. 5 shows effects of marination on visual color
in pre-rigor rectus abdominous muscle.
0019 FIG. 6 shows effects of marination on visual color
in pre-rigor cutaneous trunci muscle.
DETAILED DESCRIPTION OF THE
INVENTION

0020. The present invention relates generally to enhance
ment of desirable attributes of meat; compositions and

methods for accomplishing Such enhancement; and to the
meat enhanced by Such compositions and methods. More
particularly, the present invention relates to the treatment of
whole pre-rigor Skeletal muscle, either while on the carcass
or after excision, employing compositions of the invention
which are applied to pre-rigor muscle to obtain a significant
enhancement in tenderneSS and other desirable attributes of
meat.

0021. In accordance with the method of the present
invention a composition is applied to pre-rigor Skeletal
muscle after harvesting and evisceration. The pre-rigor
muscle may be manually or mechanically removed from the
skeleton before application of the compositions of the
instant invention. Alternatively, the entire carcass, or a
portion thereof, could be used with the skeletal muscle fully
or partially attached to the skeleton.
0022. In one embodiment of the present invention, the
method Serves to enhance one or more quality meat traits. In
a first aspect of this embodiment, the enhanced attribute is
tenderneSS. In a Second aspect of this embodiment, the
attribute is reduced detriment in lean color. In a third aspect
of this embodiment, the attribute is absence of off flavors. In

a fourth aspect, the attributes include a combination of two
or more of the above attributes.

0023. In another embodiment of the invention, the means
of application of the compositions of the present invention
to pre-rigor muscle can be carried out by any of those means
known in the art. In a first aspect of this embodiment, the
compositions of the invention may be applied by direct

injection into the muscle (pumping) when the muscle is on
the carcass. In a Second aspect of this embodiment, the
compounds of the invention may be applied by direct
injection after the muscle has been excised from the carcass.
Injection may be accomplished by manual or mechanical
means. In a third aspect of this embodiment, the composi
tions of the invention may be applied by marination of the
muscle. In a fourth aspect, the compositions may be applied
by injection into vein or artery, including infusion of the
animal body. In a fifth aspect, application of the composi
tions of the invention may be augmented by high-pressure
Spray or vacuum System for delivering the compositions to
the muscle. In a sixth aspect of this embodiment, the
compositions of the invention may be applied by a combi
nation of two or more of the above methods. Further details

of suitable methods of application are set forth in the
Examples.
0024 Compositions useful in the practice of the inven
tion include Solutions of citric acid and its Salts, glucose,
Sodium oxalate, oxamic acid, Sodium acetate, and combina

tions thereof. It is preferred to use citric acid and/or one of
its Salts, most preferably Sodium citrate. From a biochemical
perspective, it is primarily though not exclusively the citrate
portion of the molecule that directly or indirectly produces
the enhancement in quality meat trait. The concentrations of
the compositions useful in the practice of the invention can
be determined in part by the degree of enhancement desired,
and otherwise as dependent upon the method of application
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of the compositions of the invention to the muscle and the
further processing Strategies and products desired, as
described elsewhere herein. The range concentrations of
Solutions, including the compositions of the invention is
between about 0.1% to about 10% when the compositions
are to be applied by injection of muscle and preferably 0.5%
to 8%, most preferably 0.5% to 5%. When the compositions
of the invention are applied by marination, it can be desir
able to hasten uptake and therefore the range would in Some
cases be higher, between 0.1% and about 20%, preferably
0.5% to 15%. When the application is by infusion, the range
would be between about 0.1% and about 15%.

0025. The present invention will be described with ref
erence to a variety of beef muscle types as the Source of
skeletal muscle. However, it is understood that this descrip
tion is merely illustrative and the invention is applicable to
muscle of any animal which is produced for human or
animal consumption and to skeletal muscles of any mixture
of muscle fiber types. From a manufacturing perspective,
different muscle types and skeletal muscle of different
Species behave in a similar manner. For example, Virtually
all of the meat processing equipment in the industry works

on meat from any species (with the possible exception of
fish). The grinders, mixers, Stuffers, and tumblers used in a
poultry meat operation are often identical to equipment used
for beef or pork. Thus, it is appropriate to extrapolate these
results to all striated, Skeletal muscle. Biochemistry of
muscle is consistent acroSS Species to Such an extent that the
focus is on the few subtle differences rather than the simi

larities among muscle types. The post-mortem biochemistry
of all striated, Skeletal muscle is similar. They rely on

glycolysis (the degradation of endogenous glycogen) to
generate energy (ATP) within the muscle during rigor,
thereby producing lactic acid and dropping muscle pH. The
Same biological Structures exist-at both the cellular as well
as the tissue level. Given the common biochemistry of
striated Skeletal muscles, Similar results are to be expected
with Skeletal muscle, including, but not limited to, muscle of
pork, lamb, poultry, deer, bison and llama. In a first aspect
of this embodiment, the compounds may be used to enhance
attributes of beef. In a second aspect of this embodiment, the
compounds may be used to enhance attributes of pork. In a
third aspect of this embodiment, the compounds may be
used to enhance attributes of lamb. In a fourth aspect of this
embodiment, the compounds may be used to enhance
attributes of poultry. In a fifth aspect of this embodiment, the
compounds may be used to enhance attributes of llama. In
a sixth aspect of this embodiment, the compounds may be
used to enhance attributes of deer. In a Seventh aspect of this
embodiment, the compounds enhance bison.
0026. It is anticipated that the meat produced by the
method of the instant invention can be used in a wide variety
of meat products including, without limitation, meat prod
ucts that are vacuum packaged, frozen and flaked, pre
cooked and Steaks.

0027 Definitions
0028. The present invention employs the following defi
nitions:

0029) “Aging of muscle” refers to refers to the storage of
meat or muscle foods at refrigerator temperatures.
0030) “Enhanced tenderness” refers to the reduced shear
force and/or increased desirability of taste panel tenderneSS
ratings which occurs as a result of treatment.
0031) “High pH” when referring to the ultimate pH value

of muscle or meat means a pH (acidity) reading that is higher
than that normally found in muscle or meat after the comple
tion of rigor mortis.
0032) “Hot boned” and “hot boning” refers to removal of
meat from carcasses prior to rigor mortis.
0033 “Lean color” refers to the ultimate color of meat
after exposure to air and binding of oxygen to myoglobin
which impart a bright, cherry red color to the meat. Lean
color may be described in terms of redness, brightness, hue,
and many other objective and Subjective terms.
0034). “Meat” shall include, without limitation, both
cooked and uncooked meats irrespective of the State of
rigor-mortis, and all edible meats, Such as, for example,
beef, pork, lamb, deer, bison, poultry and the like.
0035 “Meat quality traits” refer to those characteristics
of meat or muscle foods that influence the appearance,
eating quality or processing quality of the meat or are
indicative of Such characteristics. Examples include color,
tenderness, flavor, juicineSS, and water holding capacity,
among others.
0036 “Meat texture” refers to the physical properties of
meat and muscle relating to eating quality, including ten
derneSS.

0037 “Microbial stability” refers to the ability of the
meat or muscle product to maintain micro-organisms at their

current level and resist (or slow) excessive growth of

Spoilage micro-organisms.
0038 “Muscle type” refers to the broad classification of
striated, skeletal muscle into categories based upon their
blend of muscle fiber type. Muscles are comprised of a mix

of muscle fiber types. Each fiber (muscle cell) can be
classified by Several different Systems as a particular type.
One example of a classification System is red, intermediate,
and white. Another is beta-red, alpha-red, and alpha white.
Still others classify as type I, type IIA, and type IIB. Each
System depends on Specific biochemical and biophysical
characteristics of the muscle. Skeletal muscles are com

prised of a blend of muscle fiber types. Thus, whole skeletal
muscles are often classified on the basis of the predominate
nature of their fiber type profile. Those with many beta-red
fibers might be considered “red” muscles while those with
many alpha-white muscle fibers would be considered
“white” muscles. This is an imperfect System because even
the “white' muscles contain Some beta-red fibers. Skeletal
muscles exhibit characteristics that can be associated with
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one or more muscle fiber types, depending on the relative
proportions of different muscle fiber types.
0039) “Off-flavor” refers to a flavor not usually associ
ated with fresh meat.

0040 “Oxidation reduction potential” refers to the bio
chemical ability of the muscle/meat to counter oxidation
through Subsequent reduction of the oxidized compounds.
0041) “Pre-rigor” refers to muscle that has not completed
the process of rigor mortis or attained its ultimate, post
Slaughter pH.
0042 “Sarcomere length” or "SL" reflects the degree of
muscle contraction present in the muscle.
0.043 “Shear force” refers to the amount of mechanical
force needed to cut a core of meat; a Standardized procedure
to provide an objective measure of meat tenderneSS.
0044) “Sodium citrate” is used herein to refer to citric
acid and its Salts, and includes Sodium citrate, calcium
citrate and other salts of citric acid. The USDA considers

citric acid and its Salts to be covered by the phrase, citric

acid. (9 CFR $318.7)
0.045 “Tenderness of meat” refers to objective measures
and/or Subjective measure of the amount of force needed to
cut or fragment cooked meat.
0046) “Whole pre-rigorskeletal muscle” refers to striated
skeletal muscle from animals used for meat.

0047 The various embodiments of the present invention
described herein are based on the discovery of compounds
which enhance meat quality traits of all types of pre-rigor
skeletal muscle. For example, Sodium citrate was identified
to enhance tenderness of muscle when used as a pre-rigor
treatment. Similar effects were found with other compounds
Such as glucose, Sodium oxalate, oxamic acid and Sodium
acetate. It has been discovered that pre-rigor muscles treated
with these compounds were Superior in tenderneSS to
untreated muscle, despite a Severe muscle shortening in
excised muscle as evidenced by reduced Sarcomere length.
Particularly Surprising was the magnitude of enhancement of
tenderneSS with the compounds of the invention and that
treated muscle color was affected to a lesser degree than it
is in muscle where ultimate pH occurs naturally or after
addition of other ingredients. Additional advantages with the
use of the compounds of the invention are more desirable
taste panel Scores for juicineSS, amount of connective tissue
and flavor. Furthermore, Sodium citrate is approved as a
chemical preservative for addition to whole muscle prod

ucts, cured products and as a Surface application. (9 CFR
$318.7(c)(4), Ch. 111 (1-1-100 Edition), U.S. Dept. Ag.
(1998)).
0048 Preliminary Trials
0049. In several preliminary trials, pre-rigor beef muscle
was tested for Several quality meat traits after treatment by
one of three procedures.

0050 Homogenized Muscle
0051 Pre-rigor beef muscle was homogenized 100 mL of
treatment solution, held at 2 C. for up to 24 hours before
testing pH and oxidation-reduction potential of the homo
genate. The treatment Solutions were as follows: Sodium
chloride (330 mM), sodium citrate (100 mM), sodium
acetate (100 mM), iodoacetate (50 mM), oxamic acid (50
mM), glucose (330 mM), sodium diphosphate (100 mM),
sodium fluoride (100 mM), sodium oxalate (50 mM), cal
cium iodate (50 mM), calcium chloride (300 mM), and
water (control). All treatments except calcium chloride pro
duced higher pH than the control. Two of the compounds are
approved food ingredients; however, iodoacetate, oxamic
acid, Sodium oxalate and calcium iodate have toxic speci
fications and regulatory limits.
0.052 Sectioned Muscle
0053 Pre-rigor beef muscle was sectioned into 100 g.
Samples at approximately 3 hours post-mortem. The pieces
were injected with 10 mL of treatment solution followed by
marination in the solution for 24 hours at 2 C. before testing
pH and recording Visual color of the muscle Sections. For
evaluation of shear force, Samples were thawed, cooked,
Sliced (approximately 6 mm by 6 mm) and then cooled
before readings were taken. The Solutions used for this
procedure were as described above for homogenized
muscle.

0054 Contrary to results suggested with the homog
enized muscle trials, not all treatments resulted in higher pH
than the control. Furthermore, results from different muscle

types varied widely as to Shear force values as compared to
the control. However, the sectioned muscle itself was very
thin with high connective tissue content, which made it
difficult to obtain accurate results for shear force. Most of the

treatment Solutions used in these procedures caused different
responses among muscle types.

0055 (FIGS. 1-6)
0056 Sectioned Muscle
0057 Pre-rigor beef muscle was sectioned and the sec
tions were injected at approximately 1 hour post-mortem
with a volume of treatment solution equal to 10% of the
muscle weight. Objective color measurements were taken on
pieces of each muscle Section and the pieces were then
frozen, powdered and stored at -80 C. for up to 10 days
before testing pH and analyzing oxidation-reduction poten
tial. Shear force was evaluated as described immediately
above. Solutions used in this procedure were as follows:

sodium citrate (200 mM), sodium acetate (200 mM), glucose
(300 mM), calcium citrate (200 mM), calcium chloride (300
mM), injection with water, and no injection (control). The
calcium citrate Solution was prepared as a Suspension using
0.25% carrageenan and 200 mM calcium citrate due to its
insolubility in water. However, use of calcium citrate can be
optimized by increasing Solubility by means known in the
art. Results are shown in Tables 1 and 2.

0058 Muscle samples used in the preliminary trials
underwent considerable physical manipulation prior to
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application of treatments and assessment of results. Excised
muscles were either homogenized in a blender or cut pre
rigor into Subsamples for application of the various treat
ments. This much manipulation would be expected to accel
erate post-mortem metabolism. As a result, it was not
possible to reliably predict the effect of treatment with the
compositions of the invention on whole skeletal muscle
when it was treated, pre-rigor, before homogenizing or

0062) 4) No changes in lightness (L*) of whole

muscle were anticipated contrary to treatment of
Sectioned muscles.

0063. It has been discovered that, with the method of the
present invention wherein pre-rigor whole muscle is treated,
citric acid and its Salts, glucose, Sodium oxalate, oxamic acid
and Sodium acetate reduce the pH decline normally
observed; rather than having the pH drop to approximately

5.6, the ultimate (post-rigor) muscle pH is higher.
TABLE 1.

Effect of pre-rigor injection on pH, oxidation-reduction potential and shear force
of sternomandibularis beef muscles.
Variable
Redox

Shear

Treatment

PH
(O h)

pH
(72 h)

Redox potential,
mV (Oh)

potential, mV
(72 h)

force, kg
(72 h)

Calcium chloride
Glucose
Sodium citrate
Sodium acetate
Calcium citrate
Control Water
Control no-water

6.77
6.81
6.86
6.86
6.92
6.95
6.84

5.88d
5.82cd
5.77bc
5.8Ocd
5.82cd
5.66ab
5.65a

131.OO
128.91
135.45
128.98
128.70
127.51
135.60

139.95
14131
152.40
131.88
126.60
141.76
145.30

6.61
13.7Ob
11.09ab
9.88ab
7.57a
14.44
14.03

.04

O3

4.04

4.21

SD

1.44

a,b,c,d

means bearing the same letters within a column are not significantly different at P <

Sectioning. Given the significant disruptions in the processes
which muscle would normally undergo, which were caused
by the homogenization and removal pre-rigor of Small
Samples for treatment and testing in the preliminary trials, it
was not possible to predict how treatment of whole skeletal

0.064
TABLE 2

Effect of pre-rigor injection on color of sternomandibularis
beef muscles.

muscle (as compared to homogenized or Sectioned) with the
Several compounds, would affect tenderneSS or other meat
quality traits. Furthermore, the preliminary trials indicated
that different muscle types responded differently to treat
ment and that use of different compounds would therefore be
required. Specifically, the following differences from Screen
ing of compounds using Sectioned or homogenized muscle
pieces, which were among those observed when the method
of the present invention was used to treat whole pre-rigor
muscle:

Variable

L*value

a value

b value

L* value

a value

Treatment

(O h)

(O h)

(O h)

(72 h)

(72 h)

Calcium
chloride
Glucose
Sodium citrate
Sodium acetate
Calcium citrate
Control Water
Control

27.53

17.03

3.16

27.75

22.90

27.86
24.27
23.60
27.37
28.07
26.45

19.26
23.82
20.17
20.41
19.03
17.08

4.29
5.16
4.69
3.89
3.82
2.57

27.57
30.83
28.64
29.05
28.05
27.01

27.53
25.10
21.26
25.27
24.65
22.51

1.69

2.22

72

2.18

1.12

no-Water

SD

0059) 1) Treatment of whole muscle with sodium
citrate produced much lower shear force values than
treatment of Sectioned Samples of flank muscle.

0060 2) All whole muscle types treated with sodium
citrate responded Similarly while Sectioned muscle
Samples responded inconsistently.

0061 3) Surprisingly, no significant differences in
oxidation/reduction (redox) potential were detected
among types of treated whole muscle. Based on
results of the preliminary trials of Sectioned muscle
Samples, differences in redox potential among
muscle types was anticipated.

Comparison within a column are not significantly different (P< .05).
*L* = lightness; 100 = white, 0 = black.
a* = redness; -80 = green, 100 = red.
*b* = yellowness: -50 = blue, 70 = yellow.
EXAMPLES

0065. The following examples are illustrative of the
present invention and are not intended to limit the Scope of
the invention. Standard techniques well-known in the art or
the techniques specifically described below are utilized.
Example 1
Pre-rigor Injection of Whole Muscle
0066 Experiment were conducted to test the effects of
pre-rigor injection of Several compounds. Effects of these

May 9, 2002

US 2002/0054941 A1

compounds on pH, color, tenderneSS and other related traits

of low-value beef cuts were investigated. Ten steers (22 to
24 mo of age, 515 to 676 kg live weight) were slaughtered
according to current industry procedures. Pre-rigor Semi

membranosus (from the round), triceps brachii and
Supraspinatus muscles (from the chuck) were excised, after
evisceration (approximately 1 hour post-mortem), from both
Sides of the carcass. Muscle Sections were randomly

assigned to the treatments: sodium citrate (NaC; 200 mM),
sodium fluoride (NaF; 200 mM), sodium acetate (NaA; 200
mM), and calcium chloride (CaCl, 300 mM). The control
Samples remained on the carcass at 2 C. for 24 hours to
Simulate commercial conditions. Following a cooling, con

trol muscles were removed from each carcass (4 replicates),
Vacuum packaged and transferred to the holding cooler with
the other cuts at 2 C. Calcium chloride treatment was

included to be compared with the other treatments.
0067. At 2 hours post-mortem, each muscle was injected
with a volume equal to 8% of the muscle weight using a
four-needle hand injector. The temperature of Solutions were

4° C. Each muscle was individually treated (2% of solution
was added to give a total of 10% of muscle weight) and
tumbled in a 75-pound capacity tumbler (Röschermatic,
Oshabrick, Germany) for 30 min to insure uniform distri
bution of the Solution.

0068 Samples of each muscle (approximately 100 g)
were taken at 0 hour (before injection), 24, and 72 hours
after injection for determination of pH, oxidation-reduction
potential, glycogen content, R-values, NAD, and NADH.
The Samples were then immediately frozen in liquid nitro
gen and stored at -80 C. until they were powdered and

analyzed. Fresh muscle samples (approximately 20 g) were
taken at 72 hours after injection and assayed immediately for
water holding capacity and Sarcomere length. Evaluation of

all traits before injection (0 hour), indicated that initial
characteristics of all meat types were Similar at the begin
ning of the experiment.

0069 Sodium citrate (NaC) treatments enhanced muscle
tenderneSS in whole pre-rigor muscle of all muscle types,
without detriment to lean color and maintained a pH which

was higher than the control. (Tables 3, 7, and 11) Injection
of NaC in Triceps brachii produced the most tender meat

(P<0.05) at 3 days. Tenderness also improved with CaCl
during aging; however, differences were of lesser magnitude

(P<0.05) after 7 days and not significant by day 14. The
Same trend was observed in SemimembranoSuS with no

(higher oxidation-reduction potential) after 3 days. Treated
muscles had higher NAD and NADH content than controls

(P<0.05); however this change did not affect lean color.
0070 Triceps Brachii Muscle
0071 All treated muscles had higher pH values and
glycogen content than control (P<0.05) at 24 and 72 hours
post-mortem, with those containing NaF and NaC having

the highest values at both sampling periods (Table 3). These
results provide clear evidence that postmortem glycolysis
was in fact inhibited. R-value is the ratio of hypoxanthine to
nucleotide concentrations, which indicates the State of rigor

mortis (Honikel and Fischer, 1977). It was not possible to
determine if muscle Sections with any treatment entered
rigor in advance of the control because no differences were
detected in R-Values at any Sampling periods, indicating that
after 24 hours, all muscles were in Similar Stages of rigor. No

differences in water holding capacity (WHC) were observed
despite differing pH values, perhaps because treated muscles
contained 10% added liquid. Sarcomeres were shorter with

all treatments than with the control (Table 4). Despite
muscle shortening, triceps brachii muscles treated with NaC

were (P<0.05) more tender after 3 days postmortem than the
control (Table 4). Improvement in tenderness was also
observed in samples treated with NaF or CaCl Treatment
with NaF and CaCl affected shear force value; however, the

affects were of lesser magnitude (P<0.05) after 7 days of
aging than after 3 days and not significant by day 14. It is
notable that treatment with NaC resulted in lower shear

force values than CaCl at day 7. Samples treated with NaA
did not improve in tenderneSS and the pH was significantly
lower at 24 and 72 hours than Samples containing NaC or
NAF.

0072. It is desired to maintain an elevated pH without
compromising color. Treatments did not affect L* and b*

values (P>0.05). There were slightly, but significantly
(P<0.05), lower a values for treated muscles (Table 5)

compared to the control at 72 hours. This may Suggest a
dilution effect due to the addition of 10% of muscle weight

as the treatment Solution. Reducing conditions (redox poten
tial), NAD and NADH content were characterized among
treatments because they are likely to affect color. Glycolytic

inhibitors (NaA, NaC and NaF) resulted in the highest NAD
concentration at 24 and 72 hours post-mortem (P<0.05), but
these differences were not of Sufficient magnitude to be
reflected in redox potential. All samples showed the trend of

significant differences. Injection of NaC, CaCl, and NaFin
Supraspinatus significantly reduced shear force by 2.22 kg,
1.73 kg, and 1.15 kg (Table 8), respectively compared with
controls at 3 days post-mortem, with no significant differ
ences with these treatments at 7 days post-mortem. How
ever, there was a significant increase in Shear force with NaA
treatment at 7 days post-mortem. Water holding capacity and
L* value were not significantly affected by type of treatment.
However, treated samples showed lower a values than the

decreasing reducing capacity (higher mV values) over time
(Table 6). No differences were found in NADH content

controls of all muscles. Treatment did not affect oxidation

evidence that glycolysis was inhibited. As expected, WHC
increased in muscles with higher pH, but these differences

reduction potential, but all muscles became more oxidative

during treatments.
0073 Supraspinatus Muscles
0074 Samples treated with NaF or NaC had higher pH

(P<0.05) than the control at 24 hours(>6.0) and 72
hours(>5.8). Those two treatments also had higher glycogen
content (P<0.05 only at 72 hours). These results provide
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were not significant (Table 7). Similar to results found in
triceps brachii, no differences were detected in R-Values at
any Sampling periods.

0075 Sarcomere lengths of treated muscles were shorter
than that of the controls (P<0.05) at 72 hours. However,
injection of NaC, CaCl, or NaF in pre-rigor Supraspinatus
reduced shear force values by 2.22 kg, 1.73 kg, and 1.15 kg,

respectively, compared with the controls at day 3 (Table 8).
TenderneSS improved over time, however, no differences

were detected (P>0.05) between treated samples and the
controls after 7 days aging.
0076 Muscles injected with NaF had the lowest a*

values (less red) and b* values (less yellow) than control
(Table 9) at 24 and 72 hours. Although not significant, NaC
and NaA treated Samples were also leSS red and yellow than
the controls. Treatments affected neither reducing potential
nor NADH content, however a slight, but significant, dif
ference in NAD was detected in treated samples. Treated
samples had higher NAD content than the controls.

0077 Semimembranosus Muscles
0078 Muscles treated with NaFor NaC had elevated pH
values and greater glycogen content than the controls at 24
and 72 days postmortem. R-values indicated that muscles

injected with NaF entered rigor more rapidly (showed a
significant high R-value at 24 hours, Table 12) than the
controls, indicating NaF arrested glycolysis for at least 3
days.

0079 All treated samples had shorter sarcomere length
than the control at 72 hours post-mortem (Table 12). The
Shortest Sarcomere length was observed in Samples injected

with CaCl (1.48 um) and NaF (1.53 um). The same ten
derizing effects of NaF and NaC found in Supraspinatus and
Triceps brachii samples were observed in semimembrano
SuS Samples. Significant differences between treatments

were not detected (P>0.05).
0080. Different treatments did not significantly affect L*
values, but treated Samples were less red (lower a values)
and less yellow (lower b values) than controls at 72 hours
post-mortem. All treated Samples showed a decreasing

reducing capacity (higher mV values) over time (P<0.05).
Treated Samples also had significantly higher NAD and
NADH content than the controls at 24 and 72 hours post
mortem. It was noticed that NaA produced the lowest
reducing capacity and the highest NAD and NADH content

(P<0.05).
TABLE 3

Effect of pre-rigor injection on pH, water holding capacity and glycogen content of
triceps brachi beef muscles.
Treatment

Variable

pH, Oh
pH, 24 h.
pH, 72 h

WHC, 72 h,
Glycogen, Oh
Glycogen, 24h

Glycogen, 72 h

Control

Calcium

Sodium

Sodium

Sodium

chloride

acetate"

fluoride"

Citrate"

6.77

6.78

6.76

6.71

O3

5.84b

5.8Ob

6.07a

5.97a

O5

5.61

5.28d

5.67

5.48

5.95a

33.66

40.09
39.14

36.36
49.53

35.27
48.22

37.76
38.74

1.10
3.62

30.88

28.76b
25.01 be

28.74b
27.22b

43.98
37.30a

32.93
27.58

2.78
2.26

19.66

5.72b

SE

.04

means bearing the same letters within a row are not significantly different at P < .05.

"muscles remained in the carcass at 2 C. for 24 h.

concentration: 300 mM; "concentration: 200 mM.

Water Holding Capacity, %.
umol/g muscle.

0081)
TABLE 4

Effect of pre-rigor injection on R-value, sarcomere length and shear force of

triceps brachi beef muscles.
Treatment
Variable

R-values, Oh
R-value, 24 h.
R-values, 72 h

Control

Calcium
chloride

Sodium
acetate

Sodium
fluoride

Sodium
citrate

SE

1.27
1.38

81
1.31
1.44

8O
1.31
140

86
1.28
1.38

85
1.30
1.36

O3
O2
O2

US 2002/0054941 A1

May 9, 2002

TABLE 4-continued

Effect of pre-rigor injection on R-value, sarcomere length and shear force of
triceps brachi beef muscles.
Treatment
Variable

Control

Calcium
chloride

Sodium
acetate

Sodium
fluoride

Sodium
citrate

SE

Sarcomere length (um)

2.41

131

153

141

1.62

.11

Shear force (kg), 3 d
Shear force (kg), 7 d

5.75 ab
4.16

4.95be
487b

6.47a
5.96a

5.18be
4.82

4.54
4.20

.30
18

Shear force (kg), 14 d

4.01

4.07

4.67

4.09

3.69

27

means bearing the same letters within a row are not significantly different at P < .05.
'see table 1, for treatments description.
R-value is the ratio of hypoxantine to nucleotide concentration (an indicator of rigor
mortis).

0082)

0084)
TABLE 5

TABLE 7

Effect of pre-rigor iniection on color of triceps brachii muscles.

Effect of pre-rigor injection on pH, water holding

f

capacity
and glycogen content of Supraspinatus beef muscles.
o

Treatment

Variable

Calcium Sodium Sodium Sodium
Control chloride acetate fluoride Citrate

L*values, Oh
L*values 24 h.

28.94

17.72
28.37

3.

2.

5.

I

pH, Oh

a value", 24 h.

24.64 27.23

25.08

22:40

24.54

1.27

pH, 24h

bvalue, Oh
bvalue', 24 h.

6.56

3.45
7.10

2.88
6.55

3.17
6.05

2.89
6.56

27
28

b*value', 72 h

6.5O

6.22

6.38

6.39

5.73

23

Eas th 28.19

a value, 72 h

25.26e

22.22
28.52

SE

21.61
28.34

a value,

20.76
29.58

f

Treatment

23.18ab 21.87ab 23.83be

1.22
1.01

21.18a

Calcium Sodium Sodium Sodium
Control chloride acetate fluoride Citrate

Variable

.71

-d

5.64

6.09

5.86

40.03

36.71
37.98

35.94
42.83

34.19
45.49

32.72
45.18

Glycogen", 24 h

26.37

26.75

24.43

37.37

30.43

4.39

Gl

16.79b

1931

18.10

30.46a 22.65a

2.92

5.45

h, 72 h

Treatment

Redox potential, Oh
Redox potential, 24h
Redox potential, 72 h
NAD, Oh
NAD, 24 h
NAD, 72 h.
NADH, Oh
NADH, 24 h.
NADH, 72 h

Sodium
fluoride

Sodium
citrate

SE

12037
12110
128.27
122.63
1.56
127.10
129.13
131.35
125.05
1.24
134.35
139.27
139.78
133.65
2.06
.425
.442
450
.421
O36
O67
193b
258a
261a
269a .017
O52b
117a
141
113a
146
.016

115.43
131.18

O61
.044

O8O
O62
O52

a,b,c

O87
O76
O59

O78
O60
O55

O93
O67
O51

OO4
OO4
OO4

means bearing the same letters within a row are not significantly different at P < .05.

'see table 1, for treatments description.

Redox potential is expressed as mV.
NAD and NADH are expressed as tumol/g tissue.

O2

O6

1.O1
5.49

ycogen,
'means bearing the same letters within a row are not significantly dif
ferent at P & .05.
'see table 1, for treatments description.
SWater Holding Capacity, 76.

Effect of pre-rigor injection on Redox potential and NAD-NADH content of
triceps brachi beef muscles.
Sodium
acetate

5.54

0.

.04

WHCs, 72 h
Glycogen", Oh

TABLE 6

Calcium
chloride

6.73

s

"umol/g muscle.

Control

6.72 al

s

0083)

Variable

6.81 C

5.

pH, 72 h

'means bearing the same letters within a row are not significantly different at P & .05.
'see table 1, for treatments description.
SL* = lightness; 100 = white, 0 = black.
"a = redness; -80 = green, 100 = red.
*b* = yellowness, -50 = blue, 70 = yellow.

6.75 C

SE
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0085
TABLE 8

Effect of pre-rigor injection on pH, water holding capacity and glycogen
content of Supraspinatus beef muscles.
Treatment
Control

Calcium
chloride

R-values, Oh
R-values, 24h
R-values, 72 h

1.28
1.34

85
1.26
1.43

84
1.30
1.41

.79
1.28
1.37

84
1.27
1.38

O2
O2
O2

Sarcomere length (um)
Shear force (kg), 3 d
Shear force (kg), 7 d

2.13
7.28ab
487b

1.30
5.55e
4.84

144be
7.85a
6.95a

158
6.13be
4.80

1.46
5.06
4.89

.11
49
28

Variable

Sodium
acetate

Sodium
fluoride

Sodium
citrate

SE

a,b,c

means bearing the same letters within a row are not significantly different at P < .05.

'see table 1, for treatments description.

R-value is the ratio of hypoxantine to nucleotides (an indicator of rigor mortis).

0086)
TABLE 9-continued
TABLE 9

Effect of pre-rigor iniection on color of Supraspinatus beef muscles.

Effect of pre-rigor injection on color of Supraspinatus beef muscles.

Treatment

f

Treatment

Calcium Sodium Sodium Sodium
Control chloride acetate fluoride Citrate

Variable

SE

Calcium Sodium Sodium Sodium

Variable

Control chloride acetate fluoride Citrate

SE

L*values, Oh

20.07

20.75

22.55

21.99

1.63

L*values, 24 h 29.61

28.41

31.37

28.71.

29.88

1.34

L*values, 72 h 28.99

30.86

33.68

28.21 30.51

1.66

* value", Oh

a value,

18.44

a value", 24 h 27.09: 24.80

a value, 72 h
b*value, Oh

24.19

24.27
3.27

15.69

15.23

17.50

22.65a 20.78 22.83 a

bvalue, 24 h.
b*value', 72 h

20.87

2.36

2.69

2.81

3.68

31

6.14ab
6.16

5.32a
5.41

6.29ab
5.59

32
25

descripti

See ta e 1, for treatments. escription.

L* = lightness; 100 = white, 0 = black.

.89

16.66

6.60
6.37

means bearing the same letters within a row are not significantly dif

ferent S. P f

1.26

21.67

7.2Ob
6.26

"a = redness; -80 = green, 100 = red.

*b* = yellowness, -50 = blue, 70 = yellow.

0087
TABLE 10

Effect of pre-rigor injection on Redox potential and NAD-NADH
content of Supraspinatus beef muscles.
Treatment

Variable

Control

Calcium
chloride

Sodium
acetate

Sodium
fluoride

Redox potential, Oh
Redox potential, 24h
Redox potential, 72 h

120.65
132.2O

122.45
131.OO
133.47

121.53
130.37
134.90

124.17
131.45
136.7O

NAD, Oh

Sodium
citrate

124.37
11.8.17
125.05

SE

2.04
3.98
3.98

366

355

384

387

O2

NAD, 24 h
NAD, 72 h

O91b
O37b

152ab
O89ab

212a
113

216?
O78a

148a
.098

.002
011

NADH, Oh
NADH, 24 h.

O57

O74
O66

O73
O64

O78
O56

O73
O56

OO6
OO3

NADH, 72 h

.043

O41ab

O58

O45

O35

002

means bearing the same letters within a row are not significantly different at P < .05.
'see table 1, for treatments description.
Redox potential is expressed as mV.
NAD and NADH are expressed as tumol/g tissue.
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0088)
TABLE 12-continued
TABLE 11

Effect of pre-rigor injection on R-value,
sarcomere length and shear force of semimembranosus beef

Effect of pre-rigor injection on pH, water holding
gapacity and glycogen content of Semimembranosus beef muscles.

muscles.

Treatment
Variable

Calcium Sodium Sodium Sodium
Control chloride acetate fluoride Citrate

pH, Oh

pH, 24 h.
pH, 72 h

5.54c
5.24

Treatmentf

SE

6.76

6.75

6.70

6.68

O3

5.77b
5.60

5.7O
5.38d

6.08
5.97a

5.97a
5.78B

04.
04

WHCs, 72 h

36.54

41.71

39.35

38.22

41.99

2.39

Glycogen", Oh"

-

58.18,

64.24

629O

65.12

3.59

Glycogen", 24 h 40.80° 45.90° 40.88 54.03 52.83° 3.56
Glycogen, 72 h 25.86° 37.10ab 28.64° 43.77a 45.65a 4.27
'''“means bearing the same letters within a row are not significantly dif
ferent at P &.05.
see table 1, for treatments description.

Calcium Sodium Sodium Sodium
Variable

Control chloride acetate

fluoride

Citrate

SE

R-value: is the ratio of hypoxantine to nucleotides (an indicator of rigor
mortis).

0090)

8:Water Holding Capacity, 76.

TABLE 13

":umol/g muscle.

Effect of pre-rigor injection on color of semimembranosus beef muscles.

0089)

Treatment

TABLE 12

Effect of pre-rigor injection on R-value,
sarcomere length and shear force of semimembranosus beef
muscles.

L* value, Oh

L* values, 24 h
L* values, 72 h

Treatment
Variable

Calcium Sodium Sodium Sodium
Control chloride acetate fluoride Citrate

R-value, Oh

83

82

SE

85

83

O2

R-values, 24h

1.26b

1.28b.

131ab

1.36a

1.28b

O2

R-values, 72 h

1.36

1.45

1.39

1.42

1.38

O3

Sarcomere length

1.82

1.48°

1.74 a

1.53b

1.72

.07

6.56

6.28

6.61

6.02

5.14

.46

4.90

5.36

5.78

5.56

4.41

43

4.06

4.03

5.08

4.60

3.96

38

(um)

Shear force (kg),
3d

Shear force (kg),
7d

Shear force (kg),

Calcium Sodium Sodium Sodium
Control chloride acetate fluoride Citrate

Variable

14 d

'''“means bearing the same letters within a row are not significantly dif
see table 1, for treatments description.

ferent at P&.05.

a value", Oh

SE

-

20.49

18.94

20.58

20.22

1.51

26.78
29.15

28.61
29.44

28.47
32.06

27.70
27.06

26.87
30.19

1.48
1.08

-

15.18

13.36

13.60

13.31.

1.15

a value", 24 h.

26.99 b. 25.63b

24.56ab 22.54a 25.75b

a value", 72 h

27.57

24.88.

20.99

b* value, Oh

22.48

21.38

92

1.34

2.78

2.24

2.48

2.61

17

b*value, 24h

7.08

6.83

6.34ab

5.89a

6.61 be

22

b*value',72 h

7.10

6.58

5.86

5.99

5.84

39

'''“means bearing the same letters within a row are not significantly dif
'see table , for treatments description.
ferent at P&.05.

L* = lightness; 100 = white, 0 = black.

"a = redness; -80 = green, 100 = red.
b* = yellowness, -50 = blue, 70 = yellow.

0091)
TABLE 1.4

Effect of pre-rigor injection on Redox potential and
NAD-NADH content of semimembranosus beef muscles.

Treatment
Variable

Calcium
chloride

Sodium
acetate

Sodium
fluoride

120.10

122.35

125.95

12455

1.95

118.65°

129.97

134.20a

130.07a

128.85a

2.88

137.12

127.92

142.75a

140.7Oab 132.67be

3.22.

Control

Redox potential,

Sodium
Citrate

SE

Oh

Redox potential,
24 h.

Redox potential,
72 h.

NAD, Oh

NAD24h
NAD,72h

113
O72e

525

582

551

568

O27

328ab
118be

410
192a

281
.096

306
173ab

O29
022
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TABLE 14-continued

Effect of pre-rigor injection on Redox potential and
NAD-NADH content of semimembranosus beef muscles.

Treatment
Variable

Control

Calcium
chloride

Sodium
acetate

126

O7Oa
O49a

O73a
O54ab

NADH, Oh

NADH, 24 h.
NADH, 72 h

Sodium
fluoride

Sodium
Citrate

.124

130

.121

O90b
O79e

O98b
O61ab

O72a
.066

SE

means bearing the same letters within a row are not significantly different at P3.05

'see table , for treatments description.

Redox potential is expressed as mV. NAD and NADH are expressed as tumol/g tissue.

0092 Evaluation of Shear Force, pH, Oxidation-reduc
tion Potential, Sarcomere Length, Objective Color, Water
Holding Capacity, Glycogen Content, R-value and Dinucle

otide Results (Example 1)
0093. Shear Force
0094. Tenderness of samples was evaluated by measuring
Warner-Bratzler shear force. Steaks (2.54-cm thick) from
the middle of each muscle were cut and frozen at 3, 7 and
14 days postmortem. Frozen Steaks (2.54 cm thick) were
thawed at 4 C. for 24 hours and cooked on Farberware

Open Hearth Broilers (Model 350A Walter Kidde, Bronx,
N.Y.) to an internal temperature of 40° C., turned, and
cooked to a final internal temperature of 70° C. (AMSA,
1995). Temperature was monitored using an OMEGA ther
mocouple thermometer type T (Omega Engineering, Inc.,
Stamford, Conn.) inserted into the geometric center of a
steak. The cooked steaks were chilled 2 hours at 2 C., and

then 8 cores (1.27-cm diameter) were removed parallel to

the muscle fiber orientation. Cores were sheared once each

on an Instron Universal Testing Machine model 55R1123

(Instron, Canton, Mass.) with a Warner-Braztler attachment.

The Instron was set up with a 500 kg load cell, full scale

load=1 (0-10 kg), and crosshead speed=250 mm/mim.
0.095 Muscle pH
0096 Duplicate pre-rigor samples (5 g) were weighed
from powdered Sample and homogenized (Polytron, Brink
man Instruments, New York, N.Y.) in 50 mL of 5 mM
iodoacetic acid, 150 mM potassium chloride (pH 7.0, 24
C.) to stop glycolysis (Ahn et al., 1992). The pH of the
Suspension was measured with a general purpose electrode

(Corning Glass Works, Corning, N.Y.) attached to an Orion
Model SA 720 pH meter (Orion Research, Inc., Boston,
Mass.). Post-rigor muscle pH was determined by homog
enizing 5 g of sample in 50 mL of deionized water (Winger
et al., 1979).
0097. Oxidation-Reduction Potential
0098. Oxidation-reduction potential in meat may be
influenced by addition of exogenous compounds (Rodel and
Sheuer, 1999) which may also cause color alterations in fresh
meat. However, very limited information exists regarding
redox potential of meat and its Significance on lean color.

Renerre and Labas (1987) reported that muscles with the

most unstable color showed high reducing activities. In their
Study, redox potential in all muscles increased during Storage

(higher oxidizing capacity). Contrary to results presented

herein, Anh and Maurer (1989) found that under normal
conditions, redox potential in meat decreased during post

mortem Storage.

0099 Duplicate, powdered samples (10 g) were weighed
into a Waring blender cup and blended with 0.1M phosphate

buffer (pH 6.0, 24 C.). The blender cup lid had a hole cut
with an attached vacuum hose to minimize oxygen incor
poration during the 15 Sec homogenization process. Samples
were transferred to a plastic beaker and measured with a

redox combination electrode #406080 (Corning Glass
Works, Corning, N.Y.) attached to a pH meter (Orion Model
SA 720 pH meter (Orion Research, Inc., Boston, Mass.).

Reduction values of Samples were read and recorded in
absolute mV after a 2 min equilibration. This time is enough
to get consistent and Stable reduction potential value. Pre
liminary experiments revealed that 2 min was a Sufficient
amount of time to wait with the probe imbedded in the
Sample before taking readings with the redox probe.
0100 Sarcomere Length
0101 Sarcomere length was determined by the neon laser

diffraction method (Cross et al., 1981). Fresh samples were

taken at 72 hours after injection, cut into three cubes about
1-2 cm wide, making Sure the fibers ran longitudinally, and
fixed in 3% glutaraldehyde solution in 0.1 M phosphate
buffer for approximately 4 hours. Glutaraldehyde Solution
was then replaced with 0.2 M sucrose solution. Cubes can be
stored for up to 4 days at 2 C. in this solution. Muscle fibers
were placed on a microScope Slide with a drop of the Sucrose
Solution. The diffraction bands were traced on paper, moving
the Slide around until a clear diffraction pattern was
observed. From each cube, Sarcomere length of eight fiber

Samples was determined (24 total measurements per obser
Vation). Sarcomere length was calculated using the distance
(mm) between bands and the following formula:
Length(ium) =

0.6328 xDx TV (T-- D) + 1

0102 D=distance from specimen to diffraction pat
tern screen in mm (100 mm).
0.103 T=Spacing between diffraction bands in mm.
0104 0.6328=wavelength of the laser
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01.05) Objective Color
0106 Color development, oxidation-reduction potential
and NAD/NADH content in muscles treated with the com

pounds of the invention were evaluated. When meat is first

cut, the primary color pigment (myoglobin) is in a deoxy

genated State. This gives the meat a purple tinge. When

exposed to air, the oxygen binds to myoglobin (forming
Oxymyoglobin), which gives a bright, cherry red color to the
meat. When the meat is oxidized, it converts the oxymyo
globin to metmyoglobin-the brown color of meat. The
more reducing equivalents present in muscle, the longer the
time before the brown color appears.
0107 Objective color readings were taken before injec
tion and 24 and 72 hours after injection using a Hunter Lab

method involves an exoglucosidase, Amylogucosidase, from

Aspergillus niger which hydrolyses the -O-D-(1-4) and
-C-D-(1-6)-linkages of glycogen. The glucose formed is
Specifically determined with hexokinase and glucose-6phosphate dehydrogenase. The glucose liberated after
hydrolysis of glycogen is proportional to the increase of
absorbance measured at 340 nm. Fifty till of sample was
incubated with 1 mL ATP, NADP, Glucose-6-phosphate
dehydrogenase buffer and 5 lull hexokinase at 37 C. for 15
min. Absorbance was measured at 340 nm wavelength, light
path=1 cm. The muscle glycogen content was calculated

with the following formula: Glycogen (umol glucose/g wet
muscle weight)=111.882xabsorbance. 111.882 is the dilu
tion factor.

standard observer. It was Zeroed with the black plate and
Standardized with a white plate. Three readings were taken
over the entire muscle Surface and then the average was
calculated. Readings at 24 and 72 hours post-injection were
taken after letting muscles bloom for 30 minutes. The L*, a ,
and b values were taken as indicators of lightness, redness
and yellowneSS, respectively.
0108) Water Holding Capacity
0109 Expressible moisture was measured at 72 hours
post-mortem following a centrifugal method described by

0113 R-Value
0.114) R-value measures the ratio of hypoxanthine to
nucleotides, and that ratio is an indicator of the rigor State of
muscle (Honikel and Fischer, 1977). Duplicate, frozen
samples (4 g) were homogenized with 10 mL 0.9 M per
chloric acid in a Waring stainless steel mini blender (Model
31BL92, Waring Products Division, Dynamics Corporation
of America, New Hartford, Conn.) for 30 sec. The homo
genate was filtered through Whatman #1 filter paper. An
aliquot of 0.1 mL of the filtrate was diluted into 4.9 mL 0.1
M phosphate buffer, pH 7.0. The absorption at 250 and 260
nm was measured with phosphate buffer as blank. R-value
was calculated using the following formula: R-value=Ab

Jauregui et al. (1981). Three pieces of Whatman #3 filter

Sorbance250/Absorbance 260.

Mini Scan XE Plus Model No. 451 O-L (Hunter Associates,
Reston, Va.), with a 2.5 cm port, Illuminant A and 20

paper, 5.5 cm in diameter, were folded into a thimble shape
over the outside of an inverted 16x150 mm test tube with the

#50 filter paper as the internal Surface thimble. The filter
paper was weighed before and after addition of 1.5-0.3 g
sample of muscle. The sample in the thimble was then
centrifuged in a 50-mL centrifuge tube at 30,000xg for 15
min at 4 C. The sample was removed and the paper was
reweighed. Water-holding capacity was expressed as percent
weight lost from original Sample and calculated using the
following formula:
final paper weight
initial paper weight
Expressible moisture (%) = weight of sample x 100

0110 Glycogen Content
0111 Glycogen extraction was performed in duplicate
with 3 g of frozen-powdered muscle Sample, which was
homogenized with 0.6 N perchloric acid. Amylo-O-1,4-O1,6-glucosidase from Aspergillus niger (No. A3514. Sigma
Chemical, St. Louis, Mo.) was used for the breakdown of the
glycogen molecules to free glucose following the method
described by Roehrig and Allred (1974). Homogenate was
incubated for 2 hours at 37° C., then 100 uL of 3 N
perchloric acid was added to precipitate the proteins. After
centrifugation, the Supernatant was stored at 0-4 C., until
analyzed, which was within 2 weeks.
0112 The assay for glucose was run as described by
Dalrymple and Hamm (1973) and Roehrig and Allred
(1974), using glucose-6-phosphate dehydrogenase (No.
G8878. Sigma Chemical, St. Louis, Mo.) and hexokinase
(No. H5500. Sigma Chemical, St. Louis, Mo.). Briefly, the

0115 Determination of Nicotinamide-Adenine Dinucle

otides

0116 Muscle NAD/NADH metabolism is related to the
reduction process, muscle color and the process of glyco
lysis. In the process of glycolysis, NAD is reduced during
the oxidation of glyceraldehyde 3-phosphate to 1,3 bispho
sphoglycerate and NADH is oxidized to NAD during the
reduction of pyruvate to lactate. The inhibition of glycolysis
postmortem could be expected to alter NAD and NADH
content depending on the manner in which glycolysis is

inhibited. Velazco (1998) hypothesized that inhibition of
enolase by sodium fluoride (NaF) might provoke a final
reduced state (low NAD/NADH ratio). Results presented
herein for the method of the invention were unexpected in
that they do not Support this hypothesis. Faustman and

Cassens (1991) found that gluteus medius contained less

NAD and was leSS color-Stable than longissimus muscle. In
the results presented herein, control Samples had leSS NAD
content than treated ones, although differences in color were
insignificant. The leSS intense red color detected in injected
Samples may reflect a brine injection effect. Martin-Herrera

(1998) also found that flank muscles marinated with calcium

fluoride or Sodium fluoride were less red than non-injected

muscles.

0117 Nicotinamide-adenine dinucleotide in the oxidated
state (NAD) and NADH (the reduced state) were determined
by a spectrophotometric absorption method (Klingenberg,
1985), with two different extraction methods. NAD was
extracted with acid and NADH with alkali, under Suitable

conditions.

0118 For NAD extraction, 1 g of powdered, frozen
sample and 5 mL of 0.6 N perchloric acid were vigorous
Stirring with a magnetic Stirrer. To remove protein, extracts
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were centrifuged for 5 min at 3000 to 5000xg. An aliquot of
1 mL of the Supernatant was neutralized to pH 7.2-7.4 with
1 N KOH. The reduction of NAD" was quantified by the
following reaction: Ethanol--NAD's Acetaldehyde--

NADH--H". Alcoholdehydrogenase from yeast (No. A3263.
Sigma Chemical, St. Louis, Mo.) was used to catalyze the
reaction. The concentration was calculated as the change in
extinction before and after the enzyme was added at 340 nm
wavelength, and multiplied by the dilution factor, following

the formula described by Klingenberg (1985).
0119) Alkaline extraction of NADH was performed mix
ing 2 mL of cold alcoholic potassium hydroxide Solution

(0.5N) with 200-300 mg of frozen tissue with a stirrer. After
5 min in a 90° C. shake water bath, extracts was neutralized
by slow addition of triethanolamine-HCL-phosphate mix

ture (0.5 M triethanolamine; 0.4 M KHPO, 0.1 M
KHPO) to bring the pH to 7.8. Extracts were placed at
room temperature for 10 minto allow the denatured protein
to flocculate, then centrifugation was performed for 5 min at
20,000 to 40,000xg at 4 C. An aliquot of 1 mL was taken
immediately for measurements. The lactate dehydrogenase

(No. L5432. Sigma Chemical, St. Louis, Mo.) reaction was
used for the determination of NADH, as follows: NADH

H"+Pyruvatees NAD"+Lactate.
0120) The quantification of NADH was the same as
described for NAD. The increase in extinction due to

addition of lactate dehydrogenase from Skeletal muscle was
followed.

0121 Statistical Analysis
0122) The experimental design was a complete random
ized design. Data were analyzed by ANOVA with the
General Linear Model procedure of SAS (SAS, 1995). The
treatment design was a 3 (muscle type)x5 (treatment) fac
torial arrangement. The experiment was replicated four
times. Means were separated using the Least Significant
Difference procedure (Steel and Torrie, 1980), tested on
Least Square Means at P-0.05.
0123 Two models were tested. Model I was analyzed as
a 3x5 factorial, including data from all muscles (60 obser
Vations) and independent variables were: muscle type (3),
treatments (5) and the musclextreatment interaction (3x5

factorial arrangement). The model II was a complete ran
domized design for each individual muscle type (20 obser
vations) and the independent variable was treatment (5). The
muscleXtreatment interaction was not significant (P>0.05),
therefore results from model II were followed.

Example 2
Use of Sodium Citrate to Enhance Tenderness and

Palatability of Pre-Rigor Beef Muscles
0.124 Experiments were conducted to evaluate the
response in Warner-Bratzler shear force and consumer
acceptability of muscles pumped pre-rigor with different
concentrations of Sodium citrate Solutions, while maintain

ing Skeletal restraint for 24 hours.
0.125 Thoracic limbs from 14 steers were chilled on the

carcass (controls) or removed within 2 hours post-mortem
and pumped to 10% of muscle weight with water, 200 mM
or 400 mM sodium citrate solutions. The injections were
performed at various Sites along the muscle. The control
remained on the carcass. Muscle pH and temperature were
measured immediately prior to pumping. Experimental and
control muscles were chilled at 2 C. for 24 hours. Steaks

(2.54 cm thick) were removed after 24 hours from the

Infraspinatus, Supraspinatus and Triceps brachii muscles
and were either frozen immediately or aged for another 6
days and then evaluated. A consumer panel evaluated pal
atability juicineSS, tenderneSS, connective tissue amount, and

flavor desirability) on Infraspinatus and Triceps brachii
Steaks using 9-point hedonic Scales (1 being very undesir
able and 9 being very desirable) for each trait. Warner
Bratzler shear force values were determined on 1.27 cm
diameter cores from Steaks that were broiled to an internal

temperature of 70° C.
0.126 Treatment with 400 mM sodium citrate improved
shear force values over the controls at day 1 and day 7 for
all muscles except the Triceps brachii on day 1 (Table 16).
TenderneSS ratings followed the same trend, except for the
Infraspinatus. Connective tissue amount, flavor and juici
ness of the 400 mM citrate treated-steaks (Infraspinatus and
Triceps brachii) were rated as more desirable (P<0.10) than
the controls at day 1 and day 7 (data not shown).
TABLE 1.5

Shear force and sensory ratings of muscle iniected with sodium citrate
Triceps brachi

Supraspinatus

TBR

SSP

Infraspinatus (ISP
Trait

Treatment

d1

d7

d1

d7

d1

d7

WBSF

Control

3.61 a,b

3.5Obe

3.71 a

3.59

5.24

4.78

O mM
200 mM

3.96
3.57b

3.79
3.12b

453b
3.85a

4.41c
3.57b

5.12B
409a

4.90
3.83 a

3.91

4.03

Tenderness

Flavor

400 mM

3.32

2.79a

3.55a

3.09.

Control

5.41 a,b

5.52a

4.69

4.64

O mM
200 mM

4.95b
5.36a,b

4.93
5.68a

3.99
4.81

4.13

400 mM

5.67a

5.90a

5.25a

5.48

Control
O mM

5.18a;
5.02b

4.84
4.69

5.00a
4.58b

474.
4.48
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TABLE 15-continued

Shear force and sensory ratings of muscle iniected with sodium citrate
Supraspinatus
Triceps brachi
Infraspinatus (ISP
Trait

TBR

SSP

Treatment

d1

d7

d1

d7

200 mM
400 mM

5.33a,b
5.49a

5.35a
5.41

5.23a
5.30a

487a
5.18a

d1

a,b,cMeans in the same column within each trait with different superscripts differ signifi
cantly (P<.05)
*Control versus 400 mM differ significantly at P3.10

0127 Characteristics of steaks treated with 200 mM
Sodium citrate were usually between the controls and the
400 mM concentration. Pumping with water was generally
detrimental to tenderneSS and palatability.
0128. These data indicate that a 400 mM sodium citrate

Solution may be applied to pre-rigor beef muscles (con
Strained from contraction) to enhance tenderness and palat
ability.

0129 Evaluation of Color and Microbial Stability
0130. These data indicate that sodium citrate-treated

TABLE 16-continued
Visual Color

Day

Control?carc Control?water 200 mM. NaCit 400 mM NaCit

*'''Means within the same row that have different superscripts are sig

nificantly different (p < .05).
A 5-point scale was used: 1 = Pale cherry red, 3 = Bright cherry red, 5 =
Dark purple red

0134)

muscles are Similar in color with untreated controls after two

TABLE 1.7

days of retail display. (Table 16). They start out darker, but
quickly come together.

0131 Table 17 indicates that the three muscles differed in
their response to the various treatments. Given the differ
ences in fiber type profile, this is to be expected. In general,
the 400 mM Sodium citrate caused two of the three muscles

to be slightly, but significantly, darker than controls (higher
L* values). In addition, tables 18 and 19 reveal that the 400
mM-treated Samples has similar a (redness) and b (green/
yellow) values after 1 day of retail display, compared to
untreated controls.

0132) Microbial stability is reported in table 21. There
were no differences in initial microbial load among the
treatments. However, the additional handling needed to
inject the muscles resulted in greater Overall microbial
numbers at day 5 than the uninjected control. Of greatest
interest, however, is that treatment with 400 mM Sodium

citrate showed no greater microbial growth than the control

(P>0.05) while the other treatments had greater increases in
microbial numbers.

0133) Sarcomere lengths were similar (or longer) for
treated muscles than for controls (table 20).
TABLE 16

L* Values

Muscle Control?carc
ISP
SSP
TBR

Control?water 200 mM NaCit 400 mM NaCit

42.87a
38.80
36.99

45.64
39.45
42.01

43.55
36.60
38.91

43.19
36.02
34.92

*'''Means within the same row that have different superscripts are sig

nificantly different (p < .05).

0135)
TABLE 1.8
a Values

Day

Control?carc Control?water 200 mM. NaCit 400 mM NaCit

O
1.

26.64
23.28b

27.47a
24.56a

23.92b
23.44a,b

23.94
23.33P

2
3

21.19
20.23

23.12
21.86

22.18a,b
20.84a.

21.40
20.66

4
5

18.64
18.79b

20.69a
20.32a

20.11a
20.80

19.87a
19.73a,b

*'''Means within the same row that have different superscripts are sig

nificantly different (p < .05).

0136

Visual Color

TABLE 1.9
Day

Control?carc Control?water 200 mM. NaClt 400 mM NaCit
b* Values

O
1.
2
3
4
5

3.29b
3.76b
4.19
4.14.
4.10
4.43

2.90.
3.43
3.24a
3.38
3.19
3.48

3.67
3.95b.c
4.10
4.19
4.14
4.14

4.10
4.24
4.29b
4.33b
4.29B
4.29B

Day

Control?carc Control?water 200 mM. NaCit 400 mM NaCit

O

19.68

21:23a

17.37c

17.19e

1.
2
3

19.35
18.99
18.92b

2141
21.32
21.05a

20.13a,b
19.72b
19.22b

20.14a,b
18.55
18.84
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TABLE 19-continued
b* Values

Day

Control?carc Control?water 200 mM. NaClt 400 mM NaCit

4
5

17.97b
18.90

20.33
20.37a

18.79
19.90a,b

18.25
19.34ab

''Means within the same row that have different superscripts are sig

nificantly different (p < .05).

0137)
TABLE 2.0

Sarcomere Length Values
Muscle Control?carc Control?water 200 mM NaCit 400 mM NaCit
ISP
SSP

1.97a
2.06

2.25a
2.76a

2.04
2.42a

2.09a
2.53a

TBR

2.57a

2.26a

2.35a

2.40a

*'''Means within the same row that have different superscripts are sig

nificantly different (p < .05).

0138)

0141 Application of Solutions containing water and/or
other ingredients may also be used to retain, augment,
enhance or simultaneously improve tenderness. These Solu
tions may be applied in advance of, in conjunction with, or
Subsequent to application of the invention.
Example 4
Methods of Application
0142. The compositions of the invention can be applied
through direct injection into the muscle (pumping). This can
be done manually or mechanically. Meat treated in Such a
matter could be expected to gain 3%-40% of its weight
through Such a method. Typically, the concentration of the
compositions of the invention is established in part through
a calculation of the amount of Solution to be pumped into the
meat and the net gain in weight expected to occur-as
influenced by Subsequent processing factors like dwell time,
drain time, packaging, cooking or other factors. Since the
concentration of the compositions of the invention which
can be used in a given manufacture of meat or meat product
can vary considerably with the Specific pre-treatment
method of application/post-application processing of the
manufacture, the range of concentrations used in the method
of the instant invention include from about 0.1% to about
40%.

TABLE 21

Logarithmic Microbiological Growth Values
Muscle Control?carc Control?water 200 mM NaCit 400 mM NaCit
day O

2.08

2.51

2.58

day 5

3.59a

5.7Ob

5.45

2.72

5.11b

differ-

1.50a

3.21b

2.88b

2.40a,b

eCe.

''Means within the same row that have different superscripts are sig

nificantly different (p < .05).

Example 3
Preparing the Muscle for Treatment
0.139. In preparation for treatment of the pre-rigor muscle
with the compositions of the invention, the muscle may be
manually or mechanically removed from the Skeleton. Alter
natively, the entire carcass, or a portion thereof, could be
treated with the muscle fully or partially attached to the
skeleton.

0140 General methods for treatment of muscle may be
applied before or after application of the invention. Such
methods might include, but are not limited to, the applica
tion of refrigeration, freezing, or other methods of tempera
ture reduction. Steps might also be taken to alter the bio
chemical State of the muscle, like electrical Stunning of the
animal, electrical Stimulation of the carcass or muscle, or

other physical/mechanical manipulation (including tum
bling and/or massaging with or without vacuum). Addition

ally or alternatively, it may be desired to reduce muscle size.
This could occur by grinding, slicing, macerating, chipping,
flaking, cutting or other conventional methods which could
occur before, during, or after the above-described treat
ments. Other general commercial applications may be
employed, Such as procedures to open the muscle Structure
through cutting, macerating, puncturing, pumping, extrud
ing, or Similar Strategies known in the art.

0.143 An alternative or Supplement to pumping is mari
nation of the meat in a Solution containing Some or all of the
compositions of the invention. This can occur in conjunction
With other ingredients, like Salt and phosphates, among

others. The marination (or steeping) can occur for a definite

period of time or indefinitely and may or may not be
programmed for a particular temperature and pressure.
0144. Another technique to deliver the compositions of
the invention to the muscle would be by artery or vein
injection, whereby the vascular System of the muscle is used
to help distribute the Solution containing the invention

(alone or in combination with others) into the muscle. This

approach can include infusion into the animal body. A
high-pressure spray and/or a vacuum system may be part of
the delivery mechanism.
Example 5
Post-Application Processing
0.145) A number of post-application processing steps may
be applied individually or in combination to meat treated
with the compositions of the invention to retain or enhance
the effects thereof. A time delay after treatment can be
implemented for a number of reasons, including to retain or
enhance effects of the invention, provide time for additional
processing procedures, and/or for distribution. This time
delay can range in duration from minutes to dayS. Tumbling

and/or massaging (ranging from minutes to Several hours)

can be used, alone or in conjunction with other physical/
mechanical manipulation Such as described in Examples 3

and 4 and a post-treatment marinade (as described in
Example 4) may be applied. Additionally, temperature
manipulation can be applied. This could range from freezing
and refrigeration to pre-cooking or cooking. A combination
of these Strategies would likely be used.
0146 Products treated with the invention can be pack
aged in a variety of ways. It is possible for features of the
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packaging to retain or enhance application and/or effective
neSS of the invention. For example, Vacuum packaging can
enhance uptake of a marinade. The package can help ensure

the added Solution remains within the meat (rather than
draining out of the muscle). Some packages are designed for
cooking of product within (e.g., bone-in-the-bag package)
and thus can enhance effectiveness as previously described.
0.147. Other post-treatment procedures can include size

reduction (as described in Example 3) and/or combination

with other common processing Steps, Such as treatment with
other ingredients.
Example 6
Enhancing Tenderness of Skeletal Muscle from
Other Species
0.148. From a manufacturing perspective, different
muscles types behave in a similar manner. For example,
Virtually all of the meat processing equipment in the industry

works on meat from any species (with the possible exception
of fish). The grinders, mixers, Stuffers, and tumblers used in

a poultry meat operation are often identical to equipment
used for beef or pork. Thus, it is appropriate to extrapolate
these results to all Striated, skeletal muscle. Biochemistry of
muscle is consistent acroSS Species to Such an extent that the
focus is on the few subtle differences rather than the simi

larities among muscle types. The post-mortem biochemistry
of all striated, Skeletal muscle is similar. They rely on

glycolysis (the degradation of endogenous glycogen) to
generate energy (ATP) within the muscle during rigor,

thereby producing lactic acid and dropping muscle pH. The
Same biological Structures exist-at both the cellular as well
as the tissue level. Given the common biochemistry of
striated Skeletal muscles, Similar results are to be expected
with Skeletal muscle, including muscle of pork, lamb, poul
try, bison and liama.
0149 While the invention has been disclosed in this
patent application by reference to the details of preferred
embodiments of the invention, it is to be understood that the
disclosure is intended in an illustrative rather than in a

limiting Sense, as it is contemplated that modifications will
readily occur to those skilled in the art, within the spirit of
the invention and the Scope of the appended claims.
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We claim:

1. A method of enhancing tenderness of animal meat
comprising:

a) Slaughter and eviscerate said animal,
b) excise pre-rigor Skeletal muscle of Said animal,
c) apply a composition to said excised skeletal muscle,
wherein Said application comprises injection of Said com
position into the skeletal muscle and wherein Said
composition comprises Solutions of compounds
Selected from the group consisting of citric acid, a Salt
of citric acid, glucose, Sodium oxalate, oxamic acid,
Sodium acetate and combinations thereof.

2. The method of claim 1, wherein Said compound is in

0271 Valin et al. (1982). Meat Sci. 6:257-263.
0272 Van Laacket al. (1998). J. Muscle Foods 9:185

Solution at a concentration of about 0.1% to about 10%.

0273 Velazco (1998). PERSONAL COMMUNICA

Solution at a concentration of about 0.5% to about 5%.

191.

TION. Dept. of Food Technology, Monterrey Tech.,
Mty, NL. Mexico.

0274 Watanabe et al. (1996). Meat Sci. 42: 67-78.
Weeb (1974). ENZYME AND METABOLIC INHIBI
TORS. In: H. V. Bergmeyer (Ed.) Methods of Enzy

matic Analysis (2" ed.). Vol 3. Academic Press, Inc.,

New York, N.Y.

0275) Wheeler et al. (1991). J. Anim. Sci. 69:4871
4875.

3. The method of claim 1, wherein said compound is in
Solution at a concentration of about 0.5% to about 8%.

4. The method of claim 1, wherein said compound is in
5. The method of claim 2, wherein the weight of said
solution is equal to about 3% to about 40% of the weight of
Said excised skeletal muscle.

6. The method of claim 2, wherein the weight of said
solution is equal to about 3% to about 20% of the weight of
Said excised skeletal muscle.

7. The method of claim 1, wherein said composition is
citric acid.

8. The method of claim 1, wherein said compound is a salt
of citric acid.
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9. The method of claim 8, wherein said compound is
Sodium citrate.

10. The method of claim 1, wherein said compound is
glucose.
11. The method of claim 1, wherein said compound is
Sodium oxalate.

12. The method of claim 1, wherein said compound is
oxamic acid.

13. The method of claim 1, wherein said compound is
Sodium acetate.

14. The method of claim 1, wherein said animal meat is

Selected from the group consisting of beef, pork, lamb,
poultry, deer, bison and llama.
15. A method enhancing tenderneSS of animal meat com
prising:

a) Slaughter and eviscerate said animal,
b) maintain skeletal restraint of pre-rigor Skeletal muscle
of Said animal,

c) apply a composition to said pre-rigor Skeletal muscle,
d) excise said skeletal muscle,
wherein Said application comprises injection of Said com
position into the pre-rigor Skeletal muscle, and wherein
Said composition comprises Solutions of compounds
Selected from the group consisting of citric acid, a Salt
of citric acid, glucose, Sodium oxalate, oxamic acid,
Sodium acetate and combinations thereof.

16. The method of claim 15, wherein said compound is
included in the Solution at a concentration of about 0.1% to
about 10%.

17. The method of claim 15, wherein said compound is
included in the Solution at a concentration of about 0.5% to
about 8%.

18. The method of claim 15, wherein said compound is
included in the Solution at a concentration of about 0.5% to
about 5%.

19. The method of claim 16, wherein the weight of said
solution is equal to about 3% to about 40% of the weight of
Said excised skeletal muscle.

20. The method of claim 16, wherein the weight of said
solution is equal to about 3% to about 20% of the weight of
Said excised skeletal muscle.

21. The method of claim 15, wherein said composition is
citric acid.

22. The method of claim 15, wherein said compound is a
Salt of citric acid.

23. The method of claim 22, wherein said compound is
Sodium citrate.

24. The method of claim 15, wherein said compound is
glucose.
25. The method of claim 15, wherein said compound is
Sodium oxalate.

26. The method of claim 15, wherein said compound is
oxamic acid.

27. The method of claim 15, wherein said compound is
Sodium acetate.

28. The method of claim 1, wherein said animal meat is

Selected from the group consisting of beef, pork, lamb,
poultry, deer, bison and llama.
29. A method of enhancing tenderness of animal meat
comprising:

a) Slaughter and eviscerate said animal,
b) excise pre-rigor Skeletal muscle of Said animal,
c) apply a composition to said excised skeletal muscle,
wherein Said application comprises marination in Said
composition, and wherein Said composition comprises
Solutions of compounds Selected from the group con
Sisting of citric acid, a Salt of citric acid, glucose,
Sodium oxalate, oxamic acid, Sodium acetate and com
binations thereof.

30. The method of claim 29, wherein said compound is in
Solution at a concentration of about 0.1% to about 20%.

31. The method of claim 29, wherein said compound is in
Solution at a concentration of about 0.5% to about 15%.

32. The method of claim 29, wherein said composition is
citric acid.

33. The method of claim 29, wherein said compound is a
Salt of citric acid.

34. The method of claim 33, wherein said compound is
Sodium citrate.

35. The method of claim 29, wherein said compound is
glucose.
36. The method of claim 29, wherein said compound is
Sodium oxalate.

37. The method of claim 29, wherein said compound is
oxamic acid.

38. The method of claim 29, wherein said compound is
Sodium acetate.

39. The method of claim 29, wherein said animal meat is

Selected from the group consisting of beef, pork, lamb,
poultry, deer, bison and llama.
40. The method of claim 1, wherein said injection com
prises direct injection into the Said excised skeletal muscle.
41. The method of claim 1, wherein said injection com
prises methods Selected from the group consisting of injec
tion into a vein, into an artery, by perfusion and combina
tions thereof.

42. The method of claim 15, wherein said injection
comprises direct injection into the Said excised skeletal
muscle.

43. The method of claim 15, wherein said injection
comprises methods Selected from the group consisting of
injection into a vein, into an artery, by perfusion and
combinations thereof.

44. The meat prepared by the method of claim 1.
45. The meat prepared by the method of claim 15.
46. The meat prepared by the method of claim 29.
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k
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